BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zou G, Zhou Z, Xi X, Huang R, Hu H. Pioglitazone Ameliorates Renal Ischemia-Reperfusion Injury via Inhibition of NF-κB Activation and Inflammation in Rats. Front Physiol 2021;12:707344. [PMID: 34349671 DOI: 10.3389/fphys.2021.707344] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Piret SE, Mallipattu SK. Transcriptional regulation of proximal tubular metabolism in acute kidney injury. Pediatr Nephrol 2022. [PMID: 36181578 DOI: 10.1007/s00467-022-05748-2] [Reference Citation Analysis]
2 Huang R, Zou C, Zhang C, Wang X, Zou X, Xiang Z, Wang Z, Gui B, Lin T, Hu H, Chen SY. Protective Effects of PPARγ on Renal Ischemia-Reperfusion Injury by Regulating miR-21. Oxidative Medicine and Cellular Longevity 2022;2022:1-18. [DOI: 10.1155/2022/7142314] [Reference Citation Analysis]
3 Ortona S, Barisione C, Ferrari PF, Palombo D, Pratesi G. PCSK9 and Other Metabolic Targets to Counteract Ischemia/Reperfusion Injury in Acute Myocardial Infarction and Visceral Vascular Surgery. JCM 2022;11:3638. [DOI: 10.3390/jcm11133638] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gao J, Gu Z. The Role of Peroxisome Proliferator-Activated Receptors in Kidney Diseases. Front Pharmacol 2022;13:832732. [DOI: 10.3389/fphar.2022.832732] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Luan ZL, Zhang C, Ming WH, Huang YZ, Guan YF, Zhang XY. Nuclear receptors in renal health and disease. EBioMedicine 2022;76:103855. [PMID: 35123268 DOI: 10.1016/j.ebiom.2022.103855] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Kharechkina ES, Nikiforova AB, Belosludtsev KN, Rokitskaya TI, Antonenko YN, Kruglov AG. Pioglitazone Is a Mild Carrier-Dependent Uncoupler of Oxidative Phosphorylation and a Modulator of Mitochondrial Permeability Transition. Pharmaceuticals (Basel) 2021;14:1045. [PMID: 34681269 DOI: 10.3390/ph14101045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]